Mayors neighboring Hartford launch weekly distribution to address regional food insecurity

With food insecurity a persistent concern for families, mayors from three towns neighboring Hartford banded together to launch a weekly food distribution event this month, acknowledging the challenge knows no borders.

Friday marked the first of four such events, measures to bridge the gap for families struggling amid a deadly COVID-19 pandemic that has slowed the economy and left many jobless. By 10 a.m., scores of cars wound through cones in the sprawling Rehoboth Church of God parking lot.

With little pause, cars, SUVs and trucks swept through a gantry of volunteers, who quickly loaded a gallon of milk, a box of fresh produce, meat and dairy products into trunks. Within minutes, the line had quickly diminished as the volunteers stood awaiting new arrivals until the roughly 1,700 boxes of fresh food were gone.

“We find that if we can come together, pool our resources together, it benefits the community,”

Read More

Gilead Drug Shows Promising Results In Treating COVID, Ready For Distribution Says CEO


  • Gilead’s coronavirus treatment redemsivir was found to reduce recovery time in patients by several days
  • Redemsivir and other drug treatments could serve as stopgap measures until a proper vaccine is ready and approved
  • The Trump administration and Congress re-entered negotiations about a stimulus package to help a U.S. economy hit hard by the pandemic

Final results from Gilead Sciences’ latest remdesivir trial showed the antiviral drug was effective in treating coronavirus patients and cutting recovery time by at least a week.

Gilead’s CEO said, given the positive results, the company was ready for mass production and distribution of the drug.

As of Friday, Johns Hopkins said the U.S. has over 7.6 million confirmed cases of coronavirus and 212,805 reported deaths from it. The latest trial was conducted for nearly a month and involved over 1,062 patients hospitalized for coronavirus. Half of the patients were given remdesivir while the

Read More

China joins WHO’s plan for global distribution of COVID-19 vaccine

Oct. 9 (UPI) — China on Friday said it has joined a World Health Organization-led initiative that aims to manufacture and provide equitable access to a COVID-19 vaccine.

Hua Chunying, a spokeswoman for China’s foreign ministry, said the Asian nation signed an agreement with Gavi on Thursday to join COVAX, the vaccine pillar of the WHO’s Access to COVID-19 Tools Accelerator program.

Launched in April by the WHO, the ACT Accelerator aims to ramp up development, production and equitable distribution of COVID-19 tests, treatments and vaccines, and is co-led by the U.N. health body, Gavi and the Coalition for Epidemic Preparedness Innovations.

Hua did not state China’s financial contribution to the program but said it pledges to make domestically developed vaccines a public resource.

“This is an important step China has taken to uphold the concept of a shared community of health for all and to honor its commitment to

Read More

Gilead Sciences resumes control of remdesivir distribution

Mannequins with face masks and designer clothing fill a window at a Diane Von Furstenberg store in New York City on September 8, 2020. Photo by John Angelillo/UPI | License Photo

A woman wears a face mask while looking at clothing at Diane Von Furstenberg in New York City on September 8. The CFDA announced in June that New York Fashion Week shows will run for only three days in September due to the coronavirus pandemic. Photo by John Angelillo/UPI | License Photo

A girl rides a scooter in Battery Park with a view of the Statue of Liberty in New York City on September 8. Photo by John Angelillo/UPI | License Photo

Visitors wear face masks as they tour the Whitney Museum of American Art as it reopens on September 3 after being closed for over six months. Photo by John Angelillo/UPI | License Photo

Artist Akheneten Komohetep III

Read More

Moderna Coronavirus Vaccine Won’t Be Ready For Distribution Until Spring 2021


  • Moderna’s candidate vaccine may not be ready for widespread distribution until next spring
  • The company CEO said they could get an approval by the early second quarter of 2021
  • Trump has repeatedly claimed a vaccine will be available to the general population in weeks

Biotech company and coronavirus vaccine frontrunner Moderna announced Tuesday that its vaccine candidate would not be ready for widespread distribution until next spring. 

In an interview with the Financial Times, Moderna CEO Stephane Bancel said the company is unlikely to seek emergency authorization from the U.S. Food and Drug Administration for frontline workers and at-risk individuals until Nov. 25, at the earliest. 

Bancel also spoke at a health conference on Wednesday, saying the drugmaker would not seek approval for use in the general population until late January 2021. If the vaccine is proven to be safe and effective, its approval could take until early

Read More

Washington Issues Update On Coronavirus Vaccine Distribution Plan

SEATTLE — While it’s unlikely that there will be an effective, publicly available vaccine for the coronavirus this month, Washington state is putting together plans to be able to quickly distribute that vaccine when it does finally arrive.

The Washington State Department of Health issued an update on their COVID-19 vaccine distribution plans Wednesday. The DOH has received $5 million in federal funding to prepare for future vaccine distribution. They say that money will allow them to partner with local health departments, tribal nations, and community organizations to make sure the vaccine is given out fairly and quickly when it arrives.

According to the DOH, preparations are going ahead smoothly, and if a vaccine is available by November, Washington will be fully prepared to launch their vaccine distribution plan. Medical providers will likely be enrolled in the plan later before the end of October, and the state will be ready

Read More adapts its software for pandemic vaccine distribution

(Reuters) – on Wednesday said it has adapted some of its business software to help healthcare organizations and government entities distribute vaccines for the novel coronavirus once they become available.

The San Francisco-based company said the offering, called for Vaccines, will help cities, states and health-care groups track vaccine inventory levels, create online appointment portals and track how patients fare after being vaccinated.

Multiple companies and nations around the world are racing to develop a vaccine to provide some degree of immunity to the coronavirus, which causes the disease COVID-19. The chief executive of GlaxoSmithKline, the world’s largest maker of vaccines, on Tuesday said she was optimistic the industry will be able to make vaccine widely available next year.’s efforts build on tools rolled out in May aimed at modifying the company’s business software to help governments make re-opening decisions based on public health data and carry

Read More

Neptune Wellness Inks Distribution Deal With Global Consumer Goods Company

(RTTNews) – Neptune Wellness Solutions, a Canada-based health and wellness as well as cannabis extraction company, has entered into a distribution partnership with one of the world’s leading consumer goods companies. However, the company did not disclose the name of the consumer goods company.

But Neptune had announced on Twitter in late August that it has executed an agreement with consumer goods giant Unilever plc as an import and stocking master distributor as well as logistics partner in the U.S. and Canada.

“We will expand their portfolio of products to include Suave, Lifebuoy and Dove products, hand sanitizing wash, wipes & gels and face masks,” Neptune had tweeted.

Neptune said in a press release last week that as a master distributor for the global consumer goods company, it additionally expects to expand its reach into major North American retailers to create new distribution opportunities for Neptune branded consumer packaged goods

Read More

Neptune Wellness Solutions Inc. (NEPT) Secures Supply Agreement with British Columbia Liquor Distribution Branch (BCLDB)

The MarketWatch News Department was not involved in the creation of this content.

Sep 24, 2020 (Marijuana Stocks via COMTEX) —
Neptune Wellness Solutions Inc. Secures Supply Agreement with British Columbia Liquor Distribution Branch (BCLDB)

Neptune Wellness Solutions Inc. (“Neptune” or the “Company”) (NASDAQ: NEPT) (TSX: NEPT) has entered into an agreement with the British Columbia Liquor Distribution Branch (BCLDB), the wholesaler and public retailer of non-medical cannabis throughout the province, for the sale and distribution of Neptune’s new proprietary Mood Ring product line.


“We are pleased to be partnering with BCLDB to bring Mood Ring to the province of British Columbia. This will allow Neptune to bring the benefits of legal cannabis to a larger group of people,” said Michael Cammarata, Chief Executive Officer and President of Neptune.


The agreement marks the launch of Neptune’s Mood Ring product line for sale into the Canadian non-medical

Read More

Toms River Food Distribution Uplifts Volunteers, Needy Alike

TOMS RIVER, NJ — “How many families? How many people?”

It’s a question Jeanette Schlapfer asks dozens of times each Friday as cars and SUVs pull up in front of the Presbyterian Church of Toms River, arriving to pick up food to get them and their loved ones through another week.

The quick questions — How many families? How many people? — help the dozen or so volunteers working alongside Schlapfer determine how many boxes of food to load into each vehicle. But they also are emblematic of the bigger problem of food insecurity.

Food insecurity has long existed in America and in Ocean County. Even in times where joblessness has been low, there have been people in need of help feeding themselves and their families.

An estimated 37.2 million Americans, including 11 million children, were considered food insecure under U.S. Department of Agriculture guidelines before the coronavirus pandemic hit.

Read More